Research programme: dopamine receptor agonists - DarPharma

Drug Profile

Research programme: dopamine receptor agonists - DarPharma

Alternative Names: DAR 0300

Latest Information Update: 30 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator DarPharma
  • Class Small molecules
  • Mechanism of Action Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Attention-deficit hyperactivity disorder; Autistic disorder; Male sexual dysfunction; Restless legs syndrome

Most Recent Events

  • 29 Jun 2004 Preclinical trials in Attention-deficit hyperactivity disorder in USA (unspecified route)
  • 29 Jun 2004 Preclinical trials in Autism in USA (unspecified route)
  • 29 Jun 2004 Preclinical trials in Male sexual dysfunction in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top